Ureteral Stents Industry Production, Revenue, Price And Gross Margin with Top Players Applied Medical, Allium Medical, Bard Medical, B.Braun, Boston Scientific, Cook Medical, Coloplast, Conmed

Ureteral stents are minimally-invasive method of maintaining ureteral drainage to ensure renal function and treat pain caused due to ureteral obstruction. These stents are an integral part of the treatment of different urological conditions such as malignant obstruction, nephrolithiasis, ureteral stricture, ureteral injury, and healing.

Increasing prevalence of urinary incontinence with age and rising geriatric population are major factors expected to drive the ureteral stents market growth during the forecast period. According to the Global Forum for Incontinence held in 2014, incontinence is a serious medical condition and set of diseases, which affected 4% to 8% of the population or the lives of around 400 million people worldwide over a period of 2007-2010. Furthermore, lifestyle associated disorders such as obesity and diabetes increase the risk of kidney stone formation, which eventually requires ureteral stents usage during severe condition. According to the Journal of Materials Science report 2008, urolithiasis affects around 12% of the world population at some stage in their lifetime. Although it affects people of all ages, sexes, and races, it is more frequent in men than in women within the age of 20–49 years.

The global ureteral stents market size was valued at US$ 492.6 million in 2017 and is expected to witness a CAGR of 5.7% over the forecast period (2018 – 2026).

Currently, there is no ideal stent available that does not experience failures and complications. Manufacturers are focusing on various advancements in materials, design, and coating of ureteral stents. These advancements aim to address specific causes of stent’s failure, especially biofilm formation and encrustation. In 2016, BrightWater Medical received FDA approval for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. Combining the most appropriate material, design, and coating would allow the development of an optimal stent.

Request For Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/2172

New designs such as a helically-cut ureteral stent is aimed to stretch and conform the ureter. Drug-eluting stents with an antimicrobial property are designed to reduce bacterial adherence to ureteral stents. Furthermore, bioabsorbable stents are designed to reduce infection and prevent the forgotten stent syndrome. In June 2018, HydrUStent, a startup based at the University of Minho in Portugal, announced its research on developing a ureteral stent made from a patented material that is homogeneous, antibacterial, and biodegradable.

Rising prevalence of urolithiasis worldwide owing to changes in lifestyle such as lack of physical activity and dietary habits is the major factor driving the ureteral stents market revenue. Urolithiasis is a common urologic problem and constitutes a significant burden on the health care system. According to the National Health and Nutrition Examination Survey (NHANES) 2003 report, the prevalence of urolithiasis has increased over the last three decades in the U.S. and projected to experience economic burden, with an additional value of US $1.24 billion per year by 2030.

Along with elderly and adult population, kidney stones also affect children of all ages. According to the Journal of Urology 2015 data, ureteral stent placement is the most common procedures performed in approximately 20% of children with stones. The weighted average annual cost of care for pediatric urolithiasis is US $220 million per year. Urinary incontinence (UI) is also a significant health problem worldwide with increasing geriatric population rate. It has a large economic and social impact on individuals and nation. According to the European Urology 2012 report, the Epidemiology of Lower Urinary Tract Symptoms (EpiLUTS) reported relatively high UI prevalence rates of 13.3% for men and 30.3% for women in the United Kingdom, Sweden, and the U.S.

Key players operating in the global ureteral stents market include Applied Medical, Allium Medical, Bard Medical, B.Braun, Boston Scientific, Cook Medical, Coloplast, Conmed Corporation, Optimed, Olympus America, Pnn Medical A/S, Taewoong Medical, Teleflex, Uromed, and Urotech. Manufacturers in the ureteral stents market are focusing on development of less expensive products causing lower side effects than the available ones. Product innovation also comprises to address specific causes of stent’s failure, especially biofilm formation and encrustation.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2172

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.